DSP-0390

N/A

Report date: 2026/04/23 20:00:25
NME

Base Information

Drug NameDSP-0390
Drug Alias NameDSP-0390TP-0390
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEmopamil-binding protein inhibitors
TargetsEmopamil-binding protein
Therapy Area/IndicationsSmall Cell Lung CarcinomaGlioblastomaGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSumitomo Dainippon Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSumitomo Pharma America IncWashington University School Of Medicine
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaGlioblastomaGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A